Morphosys Ag (MOR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MorphoSys AG has issued a notification of major holdings, revealing that Morgan Stanley now holds a new total of 6.79% of voting rights, combining direct shares and financial instruments. This change represents a shift from the previous notification, with direct voting rights at 4.43% and voting rights through instruments at 2.36%. The announcement underscores the evolving shareholder landscape of the German biopharmaceutical company.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.